Publications by authors named "B Yaremko"

Claim this Profile
Q
Quality of Life of Stereotactic Versus Hypofractionated Radiation Therapy for Inoperable Stage I Non-Small Cell Lung Cancer: Results From the LUSTRE Trial.
Qirui Hou, Sameer Parpia, Marcin Wierzbicki, Vijayananda Kundapur, Sergio Faria, Brian Yaremko

Int J Radiat Oncol Biol Phys· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer: Long-Term Clinical Outcomes.
Vivian S Tan, Rohann J M Correa, Timothy K Nguyen, Alexander V Louie, Richard A Malthaner, Brian P Yaremko

Int J Radiat Oncol Biol Phys· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic vs Hypofractionated Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: The LUSTRE Phase 3 Randomized Clinical Trial.
Anand Swaminath, Sameer Parpia, Marcin Wierzbicki, Vijayananda Kundapur, Sergio Faria, Brian Yaremko

JAMA Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What is the predictive value of RECIST criteria following stereotactic lung radiation?
Stephanie Gulstene, Pencilla Lang, X Melody Qu, Joanna M Laba, Brian P Yaremko

Radiother Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic ablative radiotherapy before resection to avoid delay for early-stage lung cancer or oligometastases during the COVID-19 pandemic: Pathologic outcomes from the SABR-BRIDGE protocol.
Biniam Kidane, Ian J Gerard, Jonathan Spicer, Julian O Kim, Pierre O Fiset, Brian P Yaremko

Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis